Roy Suryo
An ex-politician accused of orchestrating a fraudulent coronavirus testing operation has admitted in court that the firm’s practices were not flawless, stating, "we weren’t perfect." Faisal Shoukat, a former Labour councillor for Calderdale Council, is currently on trial at Bradford Crown Court alongside four other individuals implicated in the alleged scheme run by RT Diagnostics. Among the co-defendants is the company’s co-director, Shahid Malik, a former justice minister. The prosecution contends that RT Diagnostics, based in Halifax, falsely presented itself as a legitimate testing laboratory. Instead, it is alleged that test samples were mishandled, with customers receiving fabricated negative results for COVID-19, thereby posing a significant risk to public health.
The charges against the defendants include running a fraudulent business, public nuisance, and, in the cases of Mr. Shoukat and Mr. Malik, money laundering. All defendants have pleaded not guilty to the charges. The trial has heard detailed accusations from prosecutors, who claim that RT Diagnostics "purported to be a testing laboratory" when, in reality, test kits were "dumped in a room" and customers were provided with fake negative results for the deadly virus, thereby endangering public health.
During his testimony on Wednesday, Mr. Shoukat, a pharmacist from Halifax, was pressed by prosecutor Jonathan Sandiford regarding a video published by The Sun newspaper. The footage allegedly depicted employees discarding a box of supposedly untested samples into a quarantine room that also contained a cement mixer. When challenged on whether this action was "unhygienic," Mr. Shoukat disagreed, explaining to the jury that the contents were "waste" and the room was undergoing refurbishment, emphasizing that the sample itself was sealed. He assured the court, "I can assure you that samples weren’t being dumped."
Further questioning addressed the methods employed by staff to open test kits. Mr. Shoukat defended the use of scissors and craft knives, stating it was "how we would typically open up a sample" and a common practice among other laboratories. The court has previously heard evidence that RT Diagnostics generated a substantial revenue of £6.674 million in a mere 31-day period between May 16 and June 16, 2021.
Explaining the company’s operational evolution, Mr. Shoukat remarked, "As the procedure became busier we developed, our dealings had to change." He challenged the prosecution’s portrayal of the operation, stating, "It’s been framed that a bunch of young men sat around with craft knives. You have a sample opening room with employees wearing PPE opening samples." He also asserted that there was "no hoodwinking" of the UK Accreditation Service (UKAS), the relevant accreditation body.
When questioned about why the business did not suspend its operations in light of the challenges it faced, Mr. Shoukat responded with a degree of introspection: "Hindsight is a wonderful thing. We tried our best to cope, we weren’t perfect. I have never said we were absolutely bob-on. We had to adapt, we had to change." Mr. Shoukat, who resides in Savile Park, is the first of the defendants to provide his evidence. The trial, which is anticipated to conclude in March, is ongoing.
The case of RT Diagnostics has raised serious questions about the integrity of COVID-19 testing services during the pandemic and the responsibilities of those involved in providing them. The prosecution’s allegations paint a picture of a company prioritizing profit over public safety, with a disregard for proper laboratory procedures and scientific integrity. The video evidence presented to the court, showing the alleged mishandling of samples in an unsanitary environment, has been a focal point of the trial, illustrating the prosecution’s argument that the firm operated with a profound lack of care and adherence to essential health and safety protocols.
Faisal Shoukat’s defense, while acknowledging imperfections, attempts to frame the issues as challenges of rapid growth and adaptation rather than deliberate fraud. His argument suggests that the company was attempting to scale up its operations under immense pressure, and that some procedural deviations were a consequence of this rapid expansion. The claim that samples were merely "waste" and the room was under renovation, while heard by the jury, will be weighed against the prosecution’s evidence of potentially compromised testing procedures. The mention of employees wearing Personal Protective Equipment (PPE) is an attempt to counter the image of a haphazard operation, suggesting that some safety measures were in place, even if the overall execution was flawed.
The substantial financial gains made by RT Diagnostics in such a short period have fueled the prosecution’s claims of a lucrative fraudulent enterprise. The figure of £6.674 million earned in just over a month underscores the potential scale of the alleged deception and the significant profits that could have been generated from providing substandard or non-existent testing services. This financial aspect is crucial to the money laundering charges faced by Mr. Shoukat and Mr. Malik, suggesting an intent to conceal or profit from illicit gains.
The defense’s assertion that there was "no hoodwinking" of UKAS implies that the company believed it was meeting the required standards or that any shortcomings were not intentionally concealed. However, the prosecution will likely argue that the very nature of the alleged practices—dumping samples, sending fake results—constitutes a fundamental deception, regardless of any formal accreditation processes. The interaction with UKAS, and whether RT Diagnostics misrepresented its operations or if UKAS itself failed in its oversight, could become a significant point of contention as the trial progresses.
Mr. Shoukat’s admission that "we weren’t perfect" and his acknowledgment that "I have never said we were absolutely bob-on" serve as a tactical concession. By admitting to imperfections, he aims to appear more credible and less evasive. This approach can be seen as an attempt to steer the narrative away from outright dishonesty towards a more nuanced portrayal of a business struggling to cope with overwhelming demand and operational complexities. However, the core of the prosecution’s case rests on the allegation that these "imperfections" were so severe and widespread that they amounted to a deliberate fraud that put lives at risk.
The trial’s duration, scheduled until March, indicates the complexity of the evidence and the number of witnesses expected to testify. The testimony of Mr. Shoukat, as the first defendant to give evidence, is a critical development. His account will be scrutinized by both the prosecution and the defense, and his credibility will be a key factor in the jury’s deliberations. The outcome of this trial will have significant implications for the defendants, the public perception of COVID-19 testing providers, and potentially for regulatory oversight of such services in the future. The case highlights the critical importance of transparency, accuracy, and ethical conduct in health-related businesses, especially during public health crises. The alleged actions of RT Diagnostics, if proven, represent a profound betrayal of public trust at a time when individuals were seeking reassurance and reliable information about their health.
atisusanti
Nakalama John
George Anjay
Ramos Leo